Log In
Print this Print this

subcutaneous C1-INH (CSL830)

  Manage Alerts
Collapse Summary General Information
Company CSL Ltd.
DescriptionSubcutaneous complement 1 (C1) esterase inhibitor
Molecular Target Complement 1 (C1) esterase
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentRegistration
Standard IndicationAngioedema
Indication DetailsPrevent hereditary angioedema (HAE)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today